E-Prescribing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Solutions ), Services, By Specialties, By Delivery Mode, By Substances, By Region and Competition, 2020-2030F

Description

The Global E-Prescribing Market, valued at USD 2.94 Billion in 2024, is projected to experience a CAGR of 8.39% to reach USD 4.77 Billion by 2030. E-prescribing refers to the electronic generation, transmission, and fulfillment of medical prescriptions, replacing traditional paper-based methods to enhance efficiency and patient safety. The market's expansion is fundamentally driven by the increasing adoption of integrated electronic health record solutions, governmental initiatives promoting digital health, and a critical need to mitigate medication errors and combat controlled substance abuse.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.94 Billion
Market Size 2030	USD 4.77 Billion
CAGR 2025-2030	8.39%
Fastest Growing Segment	Solutions
Largest Market	North America

Key Market Drivers

The increasing adoption of integrated Electronic Health Record (EHR) systems fundamentally drives the global e-prescribing market by establishing a digital infrastructure for prescription workflows. When e-prescribing is embedded within comprehensive EHR platforms, healthcare providers access patient histories, allergy information, and medication lists, enabling informed and safer prescribing. This integration boosts clinical efficiency and care coordination, streamlining the entire medication management process.

Key Market Challenges

A significant challenge impeding the global e-prescribing market expansion is the persistent issue of interoperability. Disparate electronic health record and pharmacy systems frequently lack seamless communication capabilities, resulting in fragmented patient data and substantial inefficiencies. This fragmentation creates data silos, preventing comprehensive patient information exchange necessary for accurate and safe medication management across the healthcare continuum.

Key Market Trends

The market is observing a significant trend in the integration of AI-powered clinical decision support systems, moving beyond conventional rule-based alerts to embed sophisticated artificial intelligence and machine learning capabilities. These advanced systems are engineered to analyze extensive patient data, including comprehensive medical histories, genomic information, and real-time biometric inputs, to generate highly personalized treatment recommendations. This enables prescribers to anticipate potential drug interactions with enhanced accuracy, identify subtle disease progression patterns, and tailor medication regimens precisely to individual patient needs. The integration of such intelligent tools signifies a fundamental shift towards a more proactive and data-driven approach to patient care, where decision support is not merely reactive but predictive.

Key Market Players

Oracle Corporation
Veradigm LLC
Epic Systems Corporation
Athenahealth, Inc.
NextGen Healthcare, Inc.
McKesson Corporation
Surescripts, LLC
Change Healthcare LLC
Practice Fusion, Inc.
Networking Technology, Inc.

Report Scope:

In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

E-Prescribing Market, By Product:

Solutions
Services

E-Prescribing Market, By Specialties:

Oncology
Sports Medicine
Neurology
Cardiology
Others

E-Prescribing Market, By Delivery Mode:

Web/Cloud Based
On Premise

E-Prescribing Market, By Substances:

Controlled Substances
Non-controlled Substances

E-Prescribing Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global E-Prescribing Market.

Available Customizations:

Global E-Prescribing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global E-Prescribing Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Solutions, Services)
- 5.2.2. By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others)
- 5.2.3. By Delivery Mode (Web/Cloud Based, On Premise)
- 5.2.4. By Substances (Controlled Substances, Non-controlled Substances)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America E-Prescribing Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Specialties
- 6.2.3. By Delivery Mode
- 6.2.4. By Substances
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States E-Prescribing Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Specialties
    - 6.3.1.2.3. By Delivery Mode
    - 6.3.1.2.4. By Substances
- 6.3.2. Canada E-Prescribing Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Specialties
    - 6.3.2.2.3. By Delivery Mode
    - 6.3.2.2.4. By Substances
- 6.3.3. Mexico E-Prescribing Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Specialties
    - 6.3.3.2.3. By Delivery Mode
    - 6.3.3.2.4. By Substances

7. Europe E-Prescribing Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Specialties
- 7.2.3. By Delivery Mode
- 7.2.4. By Substances
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany E-Prescribing Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Specialties
    - 7.3.1.2.3. By Delivery Mode
    - 7.3.1.2.4. By Substances
- 7.3.2. France E-Prescribing Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Specialties
    - 7.3.2.2.3. By Delivery Mode
    - 7.3.2.2.4. By Substances
- 7.3.3. United Kingdom E-Prescribing Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Specialties
    - 7.3.3.2.3. By Delivery Mode
    - 7.3.3.2.4. By Substances
- 7.3.4. Italy E-Prescribing Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Specialties
    - 7.3.4.2.3. By Delivery Mode
    - 7.3.4.2.4. By Substances
- 7.3.5. Spain E-Prescribing Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Specialties
    - 7.3.5.2.3. By Delivery Mode
    - 7.3.5.2.4. By Substances

8. Asia Pacific E-Prescribing Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Specialties
- 8.2.3. By Delivery Mode
- 8.2.4. By Substances
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China E-Prescribing Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Specialties
    - 8.3.1.2.3. By Delivery Mode
    - 8.3.1.2.4. By Substances
- 8.3.2. India E-Prescribing Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Specialties
    - 8.3.2.2.3. By Delivery Mode
    - 8.3.2.2.4. By Substances
- 8.3.3. Japan E-Prescribing Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Specialties
    - 8.3.3.2.3. By Delivery Mode
    - 8.3.3.2.4. By Substances
- 8.3.4. South Korea E-Prescribing Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Specialties
    - 8.3.4.2.3. By Delivery Mode
    - 8.3.4.2.4. By Substances
- 8.3.5. Australia E-Prescribing Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Specialties
    - 8.3.5.2.3. By Delivery Mode
    - 8.3.5.2.4. By Substances

9. Middle East & Africa E-Prescribing Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Specialties
- 9.2.3. By Delivery Mode
- 9.2.4. By Substances
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia E-Prescribing Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Specialties
    - 9.3.1.2.3. By Delivery Mode
    - 9.3.1.2.4. By Substances
- 9.3.2. UAE E-Prescribing Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Specialties
    - 9.3.2.2.3. By Delivery Mode
    - 9.3.2.2.4. By Substances
- 9.3.3. South Africa E-Prescribing Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Specialties
    - 9.3.3.2.3. By Delivery Mode
    - 9.3.3.2.4. By Substances

10. South America E-Prescribing Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Specialties
- 10.2.3. By Delivery Mode
- 10.2.4. By Substances
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil E-Prescribing Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Specialties
    - 10.3.1.2.3. By Delivery Mode
    - 10.3.1.2.4. By Substances
- 10.3.2. Colombia E-Prescribing Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Specialties
    - 10.3.2.2.3. By Delivery Mode
    - 10.3.2.2.4. By Substances
- 10.3.3. Argentina E-Prescribing Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Specialties
    - 10.3.3.2.3. By Delivery Mode
    - 10.3.3.2.4. By Substances

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global E-Prescribing Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Oracle Corporation
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Veradigm LLC
15.3. Epic Systems Corporation
15.4. Athenahealth, Inc.
15.5. NextGen Healthcare, Inc.
15.6. McKesson Corporation
15.7. Surescripts, LLC
15.8. Change Healthcare LLC
15.9. Practice Fusion, Inc.
15.10. Networking Technology, Inc.